Lactulosa [INN-Spanish]

Lactulosa [INN-Spanish] Brand names, Lactulosa [INN-Spanish] Analogs

Lactulosa [INN-Spanish] Brand Names Mixture

No information avaliable

Lactulosa [INN-Spanish] Chemical_Formula

C₂₆H₂₉FN₂O₂

Lactulosa [INN-Spanish] RX_link

http://www.rxlist.com/cgi/generic2/livostin.htm

Lactulosa [INN-Spanish] fda sheet

Lactulosa [INN-Spanish] msds (material safety sheet)

Lactulosa [INN-Spanish] Synthesis Reference

No information avaliable

Lactulosa [INN-Spanish] Molecular Weight

420.519 g/mol

Lactulosa [INN-Spanish] Melting Point

No information avaliable

Lactulosa [INN-Spanish] H₂O Solubility

>0.5 mg/mL

Lactulosa [INN-Spanish] State

Solid

Lactulosa [INN-Spanish] LogP

6.3

Lactulosa [INN-Spanish] Dosage Forms

Drops; Spray

Lactulosa [INN-Spanish] Indication

As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis.

Lactulosa [INN-Spanish] Pharmacology

Levocabastine is a selective histamine H1-receptor antagonist exerting inhibitory effects on the release of chemical mediators from mast cells and on the chemotaxis of polymorphonuclear leukocytes and eosinophils. Both histamine and antigens induced conjunctivitis can be inhibited by levocabastine. Levocabastine can also reduce symptoms of allergic rhinitis by preventing an increase in vascular permeability of nasal mucosa.

Lactulosa [INN-Spanish] Absorption

After instillation in the eye, levocabastine is systemically absorbed, albeit at low levels.

Lactulosa [INN-Spanish] side effects and Toxicity

Adverse effects include visual disturbances, dry mouth, cough, nausea, eyelid edema and lacrimation.

Lactulosa [INN-Spanish] Patient Information

Lactulosa [INN-Spanish] Organisms Affected

Humans and other mammals